Executive Director, US Access Strategy - Oncology

About the role

The Executive Director of US Market Access Strategy will lead the integrated market access strategy for BMS’s Oncology portfolio (both for inline and pipeline hematology and oncology assets), including oversight of US market access strategy development and execution. This role will partner closely with his/her Commercial counterpart(s) for the Oncology portfolio to inform access strategy development and oversee its execution.

Responsibilities

• Develop end-to-end US access strategy for BMS’ full Oncology and hematology in-line and pipeline portfolio
• Critical to understand pipeline and be able to transition global launch strategy work quickly to US post CSRE
• Represent US on the committees for access related decisions eg DEX, CRF, Price exception
• Work with and leverage the expertise of their team and functional partners (e.g., l Pricing, PASS, Field Access) to develop strategy for topics like brand pricing, launch sequencing, payer / provider contracting, payer marketing, PASS, and GTN management
• Utilize insights from an integrated understanding of MAx, the business, and external trends to develop customized access strategies for various brands / assets under the Oncology business unit
• Provide US access strategy support throughout the lifecycle of each asset (i.e., from pre-launch to LOE)
• Develop portfolio-wide standard for launch strategy. Establish objectives and metrics for access success. Measure progress towards agreed upon market access and launch objectives. Syndicate with broader leadership team and where appropriate adjust such strategies to meet year end goals
• Assess forward-looking trends in the marketplace, working with internal BMS stakeholders to develop innovative approaches to address any external challenges
• Build and lead a high performing team by attracting, developing, and retaining individuals through effective coaching and feedback
• Develop and maintain up-to-date knowledge for training of new and existing team members
• Develop market access programing to upskill team members as business priorities change
• Cultivate a culture of continuous learning and innovation by empowering teams with internal rotations both within Market Access and the broader organization
• Develop and strengthen collaboration within market access and across functions to drive alignment, knowledge sharing, and superior implementation of all market access activities

Qualifications

• Undergraduate degree required, MBA and/or post graduate degree required, PharmD preferred
• Deep understanding of the pharmaceuticals industry in Oncology therapeutics as well as specialty pharmacy benefit categories; commercial and access leadership experience in the U.S. is critical
• Deep understanding of the broad array of value, access, pricing, data & analytics, payment and HEOR skills and experience across U.S. and global markets. Demonstrated ability to utilize this knowledge to formulate and execute robust and successful access strategies in these markets
• Demonstrated ability to anticipate risk and build contingencies to maximize opportunities and to help mitigate negative impacts
• Minimum of 10 to 15 years’ experience with a strong track record in Market Access, Value and Access Marketing, and HEOR
• Demonstrated track record of leading and managing high performing, cross-functional teams or complex organizations successfully, including outstanding verbal and written communication to influence decision making
• Demonstrated understanding of the US healthcare / payer landscape with its unique regulatory environment (e.g., 340B, IRA)
• Knowledge of the Product Development and Commercialization Process
• Significant launch / commercialization experience desired
• Demonstration of all Core BMS Behaviors- Passion, Innovation, Accountability and Speed